![]() |
|||
|
|
|
|
| UPDATE: February 2009 | MW: 250.21 | MF: C13H8F2O3 |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
intraperitoneal | mouse
100 mg/kg
|
MUREAV 370,1,1996
|
cytogenetic analysis
|
oral | mouse
350 mg/kg
|
MUREAV 370,1,1996
|
sister chromatid exchange
|
intraperitoneal | mouse
50 mg/kg
|
MUREAV 370,1,1996
|
sister chromatid exchange
|
oral | mouse
350 mg/kg
|
MUREAV 370,1,1996
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | rat
lowest published toxic dose: 500 mg/kg (9-10 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Cardiovascular (circulatory) system
BDERB* 68,47,2003
|
oral | rabbit
lowest published toxic dose: 520 mg/kg (6-18 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Musculoskeletal system
TJADAB 30,319,1984
|
oral | rabbit
lowest published toxic dose: 780 mg/kg (6-18 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants)
|
TJADAB 30,319,1984
|
oral | rabbit
lowest published toxic dose: 750 mg/kg (9-11 day pregnant)
|
Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Specific developmental abnormalities: Eye, ear
BDERB* 68,47,2003
|
oral | rabbit
lowest published toxic dose: 750 mg/kg (9-11 day pregnant)
|
Reproductive: Specific developmental abnormalities: Cardiovascular (circulatory) system
|
BDERB* 68,47,2003
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lethal dose (50 percent kill): 124 mg/kg
|
N/R
|
IYKEDH 15,688,1984
|
intraperitoneal | rat
lethal dose (50 percent kill): 159 mg/kg
|
N/R
|
IYKEDH 15,688,1984
|
intravenous | rat
lowest published toxic dose: 500 mg/kg
|
Liver: Other changes | Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
BCPCA6 67,2141,2004
|
oral | human
lowest published toxic dose: 71 mg/kg/5 day- intermittent
|
Behavioral: Tolerance | Liver: Jaundice, cholestatic
BMJOAE 2,736,1978
|
oral | man
lowest published toxic dose: 429 mg/kg/17 week- intermittent
|
Blood: Angranulocytosis | Nutritional and Gross Metabolic: Body temperature increase
ANZJB8 16,811,1986
|
oral | mouse
lethal dose (50 percent kill): 439 mg/kg
|
Behavioral: Tremor | Behavioral: Ataxia Lung, Thorax, or Respiration: Respiratory depression
BCPHBM 4,19S,1977
|
oral | rat
lethal dose (50 percent kill): 392 mg/kg
|
N/R
|
IYKEDH 15,688,1984
|
oral | rabbit
lethal dose (50 percent kill): 603 mg/kg
|
Behavioral: Tremor | Behavioral: Ataxia Lung, Thorax, or Respiration: Respiratory depression
BCPHBM 4,19S,1977
|
subcutaneous | mouse
lethal dose (50 percent kill): 212 mg/kg
|
N/R
|
NIIRDN -,555,1995
|
subcutaneous | rat
lethal dose (50 percent kill): 185 mg/kg
|
N/R
|
IYKEDH 15,688,1984
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | rat
lowest published toxic dose: 800 mg/kg/4 day- intermittent
|
Gastrointestinal: Ulceration or bleeding from stomach | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
TXAPA9 52,454,1980
|
oral | rat
lowest published toxic dose: 9,400 mg/kg/14 week- intermittent
|
Gastrointestinal: Other changes | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
BCPHBM 4,19S,1977
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
TOXICOLOGY REVIEW
|
|
MUREAV 488,151,2001
|
TOXICOLOGY REVIEW
|
|
EMMUEG 43,143,2004
|
TOXICOLOGY REVIEW
|
|
APHRER 38,1159,2004
|
TOXICOLOGY REVIEW
|
|
EJIME* 17,529,2006
|
TOXICOLOGY REVIEW
|
|
DIMON* 39,678,1993
|
TOXICOLOGY REVIEW
|
|
TOPADD 32(Suppl. 2),71,2004
|
TOXICOLOGY REVIEW
|
|
FCLPH* 17,393,2003
|
TOXICOLOGY REVIEW
|
|
PHREP* 59,247,2007
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X6814 |
Number of Industries 1; Total Number of Facilities 16; Number of Occupations 1; Total Number of Employees Exposed 94; Total Number of Female Employees Exposed 62 | |||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
N/R
|
| ||
REFERENCES:
CODEN
|
|
REFERENCE
ANZJB8
|
Australian and New Zealand Journal of Medicine. (Modern Medicine of Australia Pty., Ltd., 100
Pacific Highway, North Sydney, 2060, Australia) V.1- 1971-
|
APHRER
|
Annals of Pharmacotherpy. (Harvey Whitney Books Co., POB 42696, Cincinnati, OH 45242) V. 26-
1992-
|
BCPCA6
|
Biochemical Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY
10523) V.1- 1958-
|
BCPHBM
|
British Journal of Clinical Pharmacology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford,
UK) V.1- 1974-
|
BDERB*
|
|
BMJOAE
|
British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR,
UK) V.1- 1857-
|
DIMON*
|
Disease-a Month (Chicago : Year Book Publishers) V. 24- 1978-
|
EJIME*
|
European Journal of Internal Medicine: The Official Journal of the European Federation of
Internal Medicine (EFIM) (Elsevier) V.10- 1999-
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
FCLPH*
|
Fundamental & Clinical Pharmacology (Oxford : Blackwell Science) 2001-
|
IYKEDH
|
Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho Kyokai, 12-15, 2-chome,
Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NIIRDN
|
Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan)
|
PHREP*
|
|
TJADAB
|
Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.1- 1968-
|
TOPADD
|
Toxicologic Pathology. (c/o Dr. F.A. de la Iglesia, Warner-Lambert Co., Pharmaceutical
Research Div., POB 1047, Ann Arbor, MI 48106) V.6(3/4)- 1978-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
| |